5th Annual Advances in Immuno-Oncology Congress
May 21 - 22, 2020 - London GBOxford Global Conferences
d.dalby@oxfordglobal.co.uk
Phone:+44 (0)1865 248455
Over 350 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions developing immuno-oncology therapies and tools. Over 60 presentations, case studies and panel discussions focussed on the key opportunities and challenges in immuno-oncology, from therapeutic strategies and biomarker development through to clinical research. PLUS, interactive opportunities including: • Workshop on Accelerating the Treatment & Response Rate of Cancer Immunotherapies • 6 roundtable discussions on key industry growth areas within immuno-oncology View Agenda: http://bit.ly/2NX4yWS Day One – 21 May 2020 • Discovery of Immuno-Oncology Therapies: Inhibitory Pathway & Cell-Based Approaches • Translational Immuno-Oncology • Personalised Therapies for Immuno-Oncology Day Two – 22 May 2020 • Discovery of Immuno-Oncology Therapies: Antibody and Virus-Based Approaches • Preclinical Development: Screening, Assays and Modelling in Immuno-Oncology • Clinical Research & Trials in Immuno- Oncology